NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1710949862 MD
Verify on CMS → Tarun Wasil, MD
Hematology & Oncology Physician in New Hyde Park, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 195 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
0%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.2/100
▲ 16 pts above national avg 83.5 · Exceptional
Industry payments
$50.9K
43 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Tarun Wasil, MD reported a CMS MIPS final score of 99.2/100 - above the 83.5 national average - and filed 1,854 Medicare Part D claims in 2023.
- 99.2/100
- MIPS score · +16 vs avg
- 2K
- Part D claims, 2023
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Tarun Wasil, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1710949862), first enumerated 04/04/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,854 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 99.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$50.9K in reported industry payments (43 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Tarun Wasil, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1710949862 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1710949862
- ENUM-LEGACY 2006
- TAX-MID 11K Hematology &
- MIPS-ELITE 99.2/100
- RX-MID 1,854
- BOOK-LIGHT 967 in New York
- PHOTO-FINISH Tim Broeseker · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Wasil · this pro…
Wasil · this provider
99.2 MIPS pts
- Jorge Perez De A…
Jorge Perez De Armas
99.2 MIPS pts
- Tim Broeseker · …
Tim Broeseker
99.2 MIPS pts
- Mansour Isckarus…
Mansour Isckarus
99.2 MIPS pts
- Janice Lawson · …
Janice Lawson
99.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Tarun Wasil, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
99 ≥ 91st percentile 91% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Tarun Wasil, MD sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Tarun Wasil, MD writes more Part D claims than 88% of them and scores higher on MIPS quality than 89% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Tarun Wasil, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Tarun Wasil, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Tarun Wasil, MD?
High performer (top quartile)Primary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,854 119% vs specialty avg
MIPS final score
99.2/100 15.7 pts vs avg
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Tarun Wasil, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 99.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1710949862 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/04/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
99.15
Final Score
Measured-score avg: 83.5
99
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Tarun Wasil, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
North Shore Hematology Oncology Associates PC
New Hyde Park, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Tarun Wasil, MD. Source: openpaymentsdata.cms.gov.
Total received
$50.9K
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Tarun Wasil, MD. To verify Tarun Wasil, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Tarun Wasil, MD - brand share 62.0%
Hematology & Oncology Physician average
62% brand-name claims vs 0% generic, on 1,854 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,854
Total Claims
$9.4M
Total Drug Cost
195
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,370
- Total Day Supply
- 62,501
- Brand vs Generic
- 62% brand / 0% generic
- Brand Drug Cost
- $8.9M
- Opioid Claims
- 37 (2.0% rate)
- Antibiotic Claims
- 36
Patient Demographics
- Average Patient Age
- 73.9 years
- Avg HCC Risk Score
- 2.71
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 19, 65-74: 79, 75-84: 69, 85+: 28
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Tarun Wasil, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Aranesp
Aranesp
131 claims
- Akynzeo
Akynzeo
99 claims
- Xgeva
Xgeva
88 claims
- Revlimid
Revlimid
66 claims
- Zarxio
Zarxio
60 claims
- Anastrozole
Anastrozole
56 claims
- Eliquis
Eliquis
54 claims
- Acyclovir 52
Acyclovir
52 claims
| Drug | Claims |
|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 131 |
| Akynzeo Fosnetupitant/Palonosetron | 99 |
| Xgeva Denosumab | 88 |
| Revlimid Lenalidomide | 66 |
| Zarxio Filgrastim-Sndz | 60 |
| Anastrozole | 56 |
| Eliquis Apixaban | 54 |
| Acyclovir | 52 |
| Kyprolis Carfilzomib | 52 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 50 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Tarun Wasil, MD fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Tarun Wasil, MD's 1,854 claims are above the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Wasil, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (99.2 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Wasil.
One of 967 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Dr. Anum Aamir
M.D
Astoria, NY
Dr. Robert Abderhalden
MD
Painted Post, NY
Dr. Mohammad Maher Abdul Hay
MD
New York, NY
Dr. George Abraham
MD
Rochester, NY
Dr. Avram Abramowitz
M.D.
Fresh Meadows, NY
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Tarun Wasil, MD's specialty? ▼
Tarun Wasil, MD specializes in Hematology & Oncology Physician and practices in New Hyde Park, New York. Credentials: MD.
How much does Tarun Wasil, MD prescribe under Medicare Part D? ▼
In 2023, Tarun Wasil, MD wrote 1,854 Medicare Part D claims totaling $9.4M in drug costs for 195 beneficiaries.
What is Tarun Wasil, MD's Medicare quality score? ▼
Tarun Wasil, MD has a CMS MIPS Final Score of 99.2/100. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Tarun Wasil, MD located? ▼
Tarun Wasil, MD is located at 1 DELAWARE DR STE 105, New Hyde Park, NY, 11042. Phone: (516) 336-5255.
What is Tarun Wasil, MD's NPI number? ▼
Tarun Wasil, MD's National Provider Identifier (NPI) is 1710949862, issued on 04/04/2006.
Does Tarun Wasil, MD prescribe more brand-name or generic drugs? ▼
Tarun Wasil, MD's prescribing is 62% brand-name and 0% generic drugs by claim count, with $8.9M in brand drug costs.
Does Tarun Wasil, MD prescribe opioids? ▼
Yes, Tarun Wasil, MD had 37 opioid claims in 2023 with an opioid prescribing rate of 2.0%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Tarun Wasil, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Tarun Wasil, MD's most frequently prescribed drugs include Aranesp, Akynzeo, Xgeva. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Tarun Wasil, MD accept Medicare? ▼
Tarun Wasil, MD appears in CMS Medicare data with 1,854 Part D claims and 195 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Tarun Wasil, MD's credentials? ▼
Tarun Wasil, MD's NPI is 1710949862 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.